May 10, 2007

INVESTOR CONTACT:

A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655

MEDIA CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

ZOLL Showcases First Wearable Defibrillator and "Code-ReadyTM" Defibrillator at Heart Rhythm 2007 Exposition  

 

 

May 10, 2007—CHELMSFORD, MASS.—ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it will display its range of resuscitation products—including the LifeVest® wearable defibrillator and the new ZOLL R Series™ defibrillator—in booth #252 at the Heart Rhythm 2007 Exposition in Denver, Colorado May 10-12.

ZOLL LifeVest: First and Only Wearable Defibrillator

The LifeVest is worn by patients at risk for sudden cardiac arrest (SCA), and it provides constant monitoring, immediate protection, and peace of mind.The LifeVest monitors the heart constantly and records patient data to help diagnose and treat life-threatening arrhythmias. If a patient is unconscious, the device continues to give alarms and spoken warnings to bystanders that a treatment shock is about to be delivered.  The entire event, from arrhythmia detection to the automatic delivery of the shock treatment, can take less than one minute. More than 100 patients’ lives have been saved to date with this technology.

ZOLL R Series

The ZOLL R Series is a Code-Ready™ device that is simple, smart, and ready to use. It offers a OneStep™ system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.

The R Series can also verify the condition and expiration date of the electrode set. All of this testing occurs without disconnecting electrodes or paddles, or requiring additional equipment to test shock delivery. The system provides a printed or electronic log to alert hospital personnel of any concerns in advance of a code. A simple green checkmark indicates that the R Series is fully ready for use.

In addition the LifeVest and to the R Series, ZOLL will also display the following products:

  • ZOLL CodeNet®, which is the first software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information. CodeNet brings new improvements and efficiencies in data capture, event time synchronization, and case and aggregate reporting. It is the only system that time stamps logged events and synchronizes these times with defibrillator data, providing clinicians with a complete and accurate timeline of an entire cardiac arrest event.
  • The ZOLL M Series® CCT, which offers ZOLL’s superior biphasic defibrillation, external pacing, complete monitoring, and a large full-color display in a single portable unit. The M Series CCT features a three-channel display for ECG and two invasive pressures with ranges covering arterial, pulmonary arterial, central venous, or intracranial, as well as two temperature channels. It also provides all the non-invasive parameter options including SpO2, EtCO2, NIBP, and fully interpretive 12-lead ECG.
  • The AutoPulse®, which is an automated, non-invasive cardiac support pump. Its load-distributing LifeBand® squeezes the entire chest in a consistent, uninterrupted “hands-free” manner, delivering improved blood flow to the heart and brain during cardiac arrest.*
  • Its line of automated external defibrillators (AEDs), the ZOLL AED Plus® and AED Pro® with Real CPR Help™. ZOLL’s Real CPR Help, first available in 2002, allows rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions.

Symposium: “Sudden Death After MI:  When an ICD Isn’t the Answer” 

ZOLL will host a breakfast symposium at 6:30 am May 11th at the Hyatt Regency Denver at the Colorado Convention Center featuring a distinguished faculty who will discuss sudden death risk and methods of protection within the first 40 days after myocardial infarction.  Topics that will be covered include outpatient sudden death high risk populations, risk factors for sudden death in ischemic cardiomyopathy and wearable defibrillator use after MI. Attendees can register online at www.lifecor.com

Test CPR Skills   

ZOLL encourages attendees to test their CPR skills using the AED Pro and AED Plus defibrillators in Booth #252.  Their CPR performance will be analyzed using CodeNet® software, which shows the effectiveness of compressions in target (i.e., best rate and depth of chest compressions).

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.

Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on February 9, 2007.

©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Code-Ready,  OneStep, R Series, and Real CPR Help are trademarks of ZOLL Medical Corporation. AED Plus, AED Pro, AutoPulse, CodeNet, LifeBand, LifeVest, M Series, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.

*Clinical data available upon request.

###